Cargando…

Heterosubtypic protective immunity against widely divergent influenza subtypes induced by fusion protein 4sM2 in BALB/c mice

BACKGROUND: Regular reformulation of currently available vaccines is necessary due to the unpredictable variability of influenza viruses. Therefore, vaccine based on a highly conserved antigen with capability of induction of effective immune responses could be a potential solution. Influenza matrix...

Descripción completa

Detalles Bibliográficos
Autores principales: Chowdhury, Mohammed YE, Seo, Soo-Kyung, Moon, Ho-Jin, Talactac, Melbourne R, Kim, Jae-Hoon, Park, Min-Eun, Son, Hwa-Young, Lee, Jong-Soo, Kim, Chul-Joong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923897/
https://www.ncbi.nlm.nih.gov/pubmed/24502341
http://dx.doi.org/10.1186/1743-422X-11-21
_version_ 1782303676882223104
author Chowdhury, Mohammed YE
Seo, Soo-Kyung
Moon, Ho-Jin
Talactac, Melbourne R
Kim, Jae-Hoon
Park, Min-Eun
Son, Hwa-Young
Lee, Jong-Soo
Kim, Chul-Joong
author_facet Chowdhury, Mohammed YE
Seo, Soo-Kyung
Moon, Ho-Jin
Talactac, Melbourne R
Kim, Jae-Hoon
Park, Min-Eun
Son, Hwa-Young
Lee, Jong-Soo
Kim, Chul-Joong
author_sort Chowdhury, Mohammed YE
collection PubMed
description BACKGROUND: Regular reformulation of currently available vaccines is necessary due to the unpredictable variability of influenza viruses. Therefore, vaccine based on a highly conserved antigen with capability of induction of effective immune responses could be a potential solution. Influenza matrix protein-2 (M2) is highly conserved across influenza subtypes and a promising candidate for a broadly protective influenza vaccine. For the enhancement of broad protection, four tandem copies of consensus M2 gene containing extracellular (ED) and cytoplasmic (CD) without the trans-membrane domain (TM) reconstituted from H1N1, H5N1 and H9N2 influenza viruses were linked and named as 4sM2. The construct was effectively expressed in Escherichia coli, purified and proteins were used to immunize BALB/c mice. Humoral and cell-mediated immune responses were investigated following administration. RESULTS: Mice were intramuscularly immunized with 4sM2 protein 2 times at 2 weeks interval. Two weeks after the last immunization, first humoral and cell mediated immune response specific to sM2 protein were evaluated and the mice were challenged with a lethal dose (10MLD(50)) of divergent subtypes A/EM/Korea/W149/06(H5N1), A/PR/8/34(H1N1), A/Aquatic bird/Korea/W81/2005(H5N2), A/Aquatic bird/Korea/W44/2005(H7N3), and A/Chicken/Korea/116/2004(H9N2) viruses. The efficacy of 4sM2 was evaluated by determining survival rates, body weights and residual lung viral titers. Our studies demonstrate that the survival of mice immunized with 4sM2 was significantly higher (80–100% survival) than that of unimmunized mice (0% survival). We also examined the long lasting protection against heterosubtype H5N2 virus and found that mice vaccinated with 4sM2 displayed 80% of protection even after 6 months of final vaccination. CONCLUSION: Taken together, these results suggest that prokaryotic expressed multimeric sM2 protein achieved cross protection against lethal infection of divergent influenza subtypes which are lasting for the long time.
format Online
Article
Text
id pubmed-3923897
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39238972014-02-15 Heterosubtypic protective immunity against widely divergent influenza subtypes induced by fusion protein 4sM2 in BALB/c mice Chowdhury, Mohammed YE Seo, Soo-Kyung Moon, Ho-Jin Talactac, Melbourne R Kim, Jae-Hoon Park, Min-Eun Son, Hwa-Young Lee, Jong-Soo Kim, Chul-Joong Virol J Research BACKGROUND: Regular reformulation of currently available vaccines is necessary due to the unpredictable variability of influenza viruses. Therefore, vaccine based on a highly conserved antigen with capability of induction of effective immune responses could be a potential solution. Influenza matrix protein-2 (M2) is highly conserved across influenza subtypes and a promising candidate for a broadly protective influenza vaccine. For the enhancement of broad protection, four tandem copies of consensus M2 gene containing extracellular (ED) and cytoplasmic (CD) without the trans-membrane domain (TM) reconstituted from H1N1, H5N1 and H9N2 influenza viruses were linked and named as 4sM2. The construct was effectively expressed in Escherichia coli, purified and proteins were used to immunize BALB/c mice. Humoral and cell-mediated immune responses were investigated following administration. RESULTS: Mice were intramuscularly immunized with 4sM2 protein 2 times at 2 weeks interval. Two weeks after the last immunization, first humoral and cell mediated immune response specific to sM2 protein were evaluated and the mice were challenged with a lethal dose (10MLD(50)) of divergent subtypes A/EM/Korea/W149/06(H5N1), A/PR/8/34(H1N1), A/Aquatic bird/Korea/W81/2005(H5N2), A/Aquatic bird/Korea/W44/2005(H7N3), and A/Chicken/Korea/116/2004(H9N2) viruses. The efficacy of 4sM2 was evaluated by determining survival rates, body weights and residual lung viral titers. Our studies demonstrate that the survival of mice immunized with 4sM2 was significantly higher (80–100% survival) than that of unimmunized mice (0% survival). We also examined the long lasting protection against heterosubtype H5N2 virus and found that mice vaccinated with 4sM2 displayed 80% of protection even after 6 months of final vaccination. CONCLUSION: Taken together, these results suggest that prokaryotic expressed multimeric sM2 protein achieved cross protection against lethal infection of divergent influenza subtypes which are lasting for the long time. BioMed Central 2014-02-06 /pmc/articles/PMC3923897/ /pubmed/24502341 http://dx.doi.org/10.1186/1743-422X-11-21 Text en Copyright © 2014 Chowdhury et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Chowdhury, Mohammed YE
Seo, Soo-Kyung
Moon, Ho-Jin
Talactac, Melbourne R
Kim, Jae-Hoon
Park, Min-Eun
Son, Hwa-Young
Lee, Jong-Soo
Kim, Chul-Joong
Heterosubtypic protective immunity against widely divergent influenza subtypes induced by fusion protein 4sM2 in BALB/c mice
title Heterosubtypic protective immunity against widely divergent influenza subtypes induced by fusion protein 4sM2 in BALB/c mice
title_full Heterosubtypic protective immunity against widely divergent influenza subtypes induced by fusion protein 4sM2 in BALB/c mice
title_fullStr Heterosubtypic protective immunity against widely divergent influenza subtypes induced by fusion protein 4sM2 in BALB/c mice
title_full_unstemmed Heterosubtypic protective immunity against widely divergent influenza subtypes induced by fusion protein 4sM2 in BALB/c mice
title_short Heterosubtypic protective immunity against widely divergent influenza subtypes induced by fusion protein 4sM2 in BALB/c mice
title_sort heterosubtypic protective immunity against widely divergent influenza subtypes induced by fusion protein 4sm2 in balb/c mice
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923897/
https://www.ncbi.nlm.nih.gov/pubmed/24502341
http://dx.doi.org/10.1186/1743-422X-11-21
work_keys_str_mv AT chowdhurymohammedye heterosubtypicprotectiveimmunityagainstwidelydivergentinfluenzasubtypesinducedbyfusionprotein4sm2inbalbcmice
AT seosookyung heterosubtypicprotectiveimmunityagainstwidelydivergentinfluenzasubtypesinducedbyfusionprotein4sm2inbalbcmice
AT moonhojin heterosubtypicprotectiveimmunityagainstwidelydivergentinfluenzasubtypesinducedbyfusionprotein4sm2inbalbcmice
AT talactacmelbourner heterosubtypicprotectiveimmunityagainstwidelydivergentinfluenzasubtypesinducedbyfusionprotein4sm2inbalbcmice
AT kimjaehoon heterosubtypicprotectiveimmunityagainstwidelydivergentinfluenzasubtypesinducedbyfusionprotein4sm2inbalbcmice
AT parkmineun heterosubtypicprotectiveimmunityagainstwidelydivergentinfluenzasubtypesinducedbyfusionprotein4sm2inbalbcmice
AT sonhwayoung heterosubtypicprotectiveimmunityagainstwidelydivergentinfluenzasubtypesinducedbyfusionprotein4sm2inbalbcmice
AT leejongsoo heterosubtypicprotectiveimmunityagainstwidelydivergentinfluenzasubtypesinducedbyfusionprotein4sm2inbalbcmice
AT kimchuljoong heterosubtypicprotectiveimmunityagainstwidelydivergentinfluenzasubtypesinducedbyfusionprotein4sm2inbalbcmice